Quantum BioPharma Ltd. (QNTM)
Quantum BioPharma Statistics
Share Statistics
Quantum BioPharma has - shares outstanding. The number of shares has increased by null% in one year.
Shares Outstanding | n/a |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Institutions (%) | n/a |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 1,161 |
FTD / Avg. Volume | 0.18% |
Short Selling Information
The latest short interest is 107.01K, so 5.58% of the outstanding shares have been sold short.
Short Interest | 107.01K |
Short % of Shares Out | 5.58% |
Short % of Float | 5.85% |
Short Ratio (days to cover) | 1.53 |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Quantum BioPharma.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | null |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | undefined |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by -59.23% in the last 52 weeks. The beta is 0.91, so Quantum BioPharma's price volatility has been higher than the market average.
Beta | 0.91 |
52-Week Price Change | -59.23% |
50-Day Moving Average | 6.56 |
200-Day Moving Average | 5.48 |
Relative Strength Index (RSI) | 65.09 |
Average Volume (20 Days) | 631,054 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | n/a |
Net Income | n/a |
EBITDA | n/a |
EBIT | n/a |
Earnings Per Share (EPS) | n/a |
Balance Sheet
Cash & Cash Equivalents | n/a |
Total Debt | n/a |
Net Cash | n/a |
Retained Earnings | n/a |
Total Assets | n/a |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
QNTM does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for QNTM.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Stock Splits
The last stock split was on Aug 15, 2024. It was a backward split with a ratio of 1:65.
Last Split Date | Aug 15, 2024 |
Split Type | backward |
Split Ratio | 1:65 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |